Emergen logo.png
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
22 janv. 2024 10h57 HE | Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period....
22157.jpg
Global Optogenetics Market Report 2024-2033: Emerging Trends in Tools & Technologies, Pharma Collaborations, Drug Discovery & Development Integration, and Non-Neural Cell Type Applications
18 janv. 2024 06h53 HE | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Optogenetics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global optogenetics market has grown rapidly in...
ocugen_4C_LOGO (002).png
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
16 janv. 2024 07h30 HE | Ocugen
MALVERN, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Professor Jerry Mendell
Distinguished Scientists with Breakthroughs in Gene Therapy for Neuromuscular Diseases, and Revolutionary RNA Discoveries , Announced as King Faisal Prize Laureates in Medicine & Science
10 janv. 2024 12h45 HE | King Faisal Foundation
Riyadh, Saudi Arabia, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Professor Jerry Mendell was announced this year’s laureate in King Faisal Prize for Medicine for his groundbreaking contributions to...
SHMNLogo.jpg
SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations
09 janv. 2024 09h30 HE | SOHM, Inc.
CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures...
Global Cell and Gene Therapy CDMO Market
Global Cell and Gene Therapy CDMO Market Analysis Report 2023: A $2.54 Billion Industry in 2022 Growing with a CAGR of 30.75% During 2024-2029
08 janv. 2024 12h53 HE | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy CDMO Market: Analysis By Type, Application, Indication, By Region, By Country: Market Insights and Forecast" report has...
EG+427+-+Main+logo+-+Full+color.png
EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)
04 janv. 2024 08h00 HE | EG 427
EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB) In a non-clinical pharmacology study in an OAB model,...
ocugen_4C_LOGO (002).png
Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
21 déc. 2023 06h30 HE | Ocugen
MALVERN, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Straits Research Pvt Ltd
Global Viral Vector Manufacturing Market Size is Estimated to Reach USD 1790 million by 2030, Growing at a CAGR of 19.7%: Straits Research
20 déc. 2023 09h20 HE | Straits Research
New York, United States, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Molecular biologists use viral vectors to introduce genetic material into cells. To treat genetic disorders, it is used to express and...
ocugen_4C_LOGO (002).png
Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations
19 déc. 2023 07h30 HE | Ocugen
RMAT designation intended to help expedite development of new regenerative medicines MALVERN, Pa., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a...